-
Dose Escalation of IL-17A Inhibitors for Psoriasis Effective, Though Risks Remain
15 Sep 2025 23:28 GMT
… among individuals living with psoriasis resulted from a recent … moderate-to-severe plaque psoriasis, many individuals need off … not all individuals with psoriasis regain their initial level … moderate-to-severe plaque psoriasis: results from the randomized …
-
Review Reveals the Hidden Burden of Psoriasis on Children, Families
15 Sep 2025 21:41 GMT
… common risk factors. Children with psoriasis frequently experienced comorbidities across multiple … limitations. Evidence on pediatric psoriasis was limited by heterogeneity in … the disease burden of pediatric psoriasis. Dermatol Ther (Heidelb). Published …
-
Johnson & Johnson seeks first EMA approval for icotrokinra for plaque psoriasis
15 Sep 2025 15:30 GMT
… with moderate-to-severe plaque psoriasis (Pso) who are 12 … or almost clear skin) and Psoriasis Area and Severity Index ( … “For people living with plaque psoriasis, the burden of disease goes … our efforts to advance plaque psoriasis care by broadening treatment …
-
Demand for Psoriasis Biosimilars Market is forecasted to reach a value of US $12.43 billion by 2029
15 Sep 2025 01:00 GMT
… The Global Psoriasis Biosimilars Market
The psoriasis biosimilars market … Disease Type: Plaque Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Pustular Psoriasis
3) By … Secukinumab Biosimilars
View the full psoriasis biosimilars market report:
https …
-
Psoriatic arthritis: Can psoriasis even damage joints?
14 Sep 2025 16:24 GMT
… of life.
What is Psoriasis?
Psoriasis is an autoimmune skin … . While many people with psoriasis experience its skin symptoms, … joint damage. People with psoriasis must consult their doctor … monitoring for patients with psoriasis. This process can help …
-
<![CDATA[Patients with Psoriasis on Biologics More Likely to Continue Use Following MACE]]>
12 Sep 2025 18:05 GMT
… systemic anti-inflammatory medications for psoriasis, though there is limited … After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study … The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events …
-
New Review Explores the Shared Genetic Backgrounds of Cardiovascular Diseases and Psoriasis
12 Sep 2025 16:54 GMT
… mortality in patients with psoriasis.
Shared Genetic Underpinnings
The … to the inflammatory processes in psoriasis, driving keratinocyte hyperproliferation and … the relationship between genetic polymorphisms, psoriasis, and cardiovascular diseases, there …
-
Fibrobiologics reports findings with HDF spheroids for psoriasis
12 Sep 2025 16:17 GMT
… IND-enabling updates from its psoriasis research program demonstrating the potential … therapeutic approach for chronic-relapse psoriasis.
BioWorld Science Dermatologic
-
Global Psoriasis Burden Doubles Since 1990
12 Sep 2025 05:31 GMT
… was utilized to forecast global psoriasis burden trends from 2022 … to 2040.
TAKEAWAY:
Global psoriasis cases nearly doubled from 2 … correlated with higher incidence of psoriasis, which was most common … that new cases of psoriasis had nearly doubled between …
-
Undertreated, Underdiagnosed: Experts Address Genital Psoriasis
11 Sep 2025 23:19 GMT
… Clinical Modification code for genital psoriasis, which could further improve documentation … impact of genital psoriasis on patients from Genital Psoriasis Wellness Consortium … -of-genital-psoriasis-on-patients-from-genital-psoriasis-wellness-consortium- …